HOME >> BIOLOGY >> NEWS
BresaGen announces Australia's first cloned pig

Australian biotechnology company, BresaGen Limited, in association with the Immunology Research Centre, St Vincent's Hospital Melbourne, has made a major breakthrough in cloning technology.

Australia's first cloned pig is now five weeks old, has been weaned and is healthy and growing normally.

It is anticipated that the new cloning technology will have a major impact in guarding against the outbreak of animal disease and in the area of xenotransplantation - the use of animal organs for transplantation into humans.

The most obvious commercial use for cloning technology is the improved breeding of livestock. Cloning allows breeders to take a small number of animals with superior genetics and rapidly produce more.

BresaGen Program Leader Dr Mark Nottle described it as "a very good result considering that this was the first transfer using our new method."

"In addition to gains in productivity, cloning could be very useful in guarding against an outbreak of diseases such as Foot and Mouth," Dr Nottle said. "Once an animal is identified as having natural resistance to a particular disease, a breeding company would use cloning to produce large numbers of animals. These animals would be supplied to farmers as breeding stock for new herds."

BresaGen President & CEO, Dr John Smeaton, said the technology used to clone the pig was unique.

"It is significantly different from the technology used to make Dolly the sheep," he explained. "Basically what works in sheep doesn't work in pigs, so we had to start from scratch. Consequently we have something new for the pig and have filed a patent application. This is an excellent result for BresaGen and is indicative of the technical strength the company has in the field of reproductive biology and embryo research."

A further application, and one of particular interest to the medical community, is xenotransplantation. Every year thousands of people around the world die while waiting for organ transplanta
'"/>

Contact: Dr Meera Verma
JAnderson@bresagen.com.au
618-8150-8220
Adelaide University
8-May-2001


Page: 1 2

Related biology news :

1. Secretary of Energy announces seven E.O. Lawrence Award Winners
2. Popular Science announces Third Annual Brilliant 10
3. The American Phytopathological Society announces 2004 awards
4. NSF announces six FIBR awards to tackle some of biologys most challenging questions
5. Protemix corporation announces discovery of way to repair hearts damaged by diabetes
6. JGI announces community sequencing program portfolio
7. APS announces the winners of its 2004 postdoctoral fellowship in physiological genomics
8. National Corn Growers Association announces valuable maize genome data now available to scientists
9. DFG announces three percent budget increase
10. Chemical Society announces EPA awards for environmentally friendly technology
11. Nanosphere announces genetic detection advance in Nature Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: BresaGen announces Australia first cloned pig

(Date:10/16/2014)... tract infections and worldwide claims the lives of ... Ghent University have succeeded in developing a promising ... , Xavier Saelens (VIB/UGent): "We discovered a ... the development of a novel approach to vaccination ... numerous small children and elderly people." , ...
(Date:10/15/2014)... ,Models of Life, is a non-traditional biophysics textbook and ... book is a journey of discovery into biological systems ... and biological regulation. It is about how our genes ... between the billions of cells in an organism. It ... between principles, which can be found on both large ...
(Date:10/15/2014)... awarded the 44th Rosenstiel Award for Distinguished Work in ... exploring the mechanisms of genomic instability and its implications ... the second alumnus to win the Rosenstiel Award; the ... , Alt is the Charles A. Janeway Professor of ... and an investigator at the Howard Hughes Medical Institute ...
Breaking Biology News(10 mins):New perspectives for development of an RSV vaccine 2New book about life as seen from physics 2Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2
(Date:10/22/2014)... October 21, 2014 The North American ... market North America with analysis and forecast of revenue. ... and is expected to reach $623.6 million by 2018, ... , Browse through the TOC of the North American ... the in-depth analysis provided. This also provides a glimpse ...
(Date:10/22/2014)... Diego, CA (PRWEB) October 22, 2014 ... balances from Sartorius, A & D Weighing, Rice ... Sartorius CPA Semi-Micro Balance . The Sartorius CPA ... for an affordable high-quality, precise, and user-friendly laboratory ... manufacturing of laboratory equipment, their laboratory balances are ...
(Date:10/22/2014)... --  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... and diseases, announced today that the U.S. Patent and ... a composition of matter patent application that covers the ... This is Synthetic Biologics, first allowed patent application directly ... the Company,s extensive C. difficile patent estate. ...
(Date:10/22/2014)... HONG KONG , Oct. 22, 2014 ... enterprise, announced today that rare disease expert John ... president, research. Dr. McKew brings more than two decades ... at the National Institutes of Health, Wyeth Research and ... McKew will lead aTyr,s efforts to expand and translate ...
Breaking Biology Technology:The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 2The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 3The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 4Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
Cached News: